Carmat SA
PAR:ALCAR
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.066
7.6805
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ALCAR stock under the Base Case scenario is 4.995 EUR. Compared to the current market price of 1.066 EUR, Carmat SA is Undervalued by 79%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Carmat SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ALCAR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Carmat SA
Balance Sheet Decomposition
Carmat SA
Current Assets | 43.4m |
Cash & Short-Term Investments | 11.4m |
Receivables | 4.5m |
Other Current Assets | 27.5m |
Non-Current Assets | 10.7m |
Long-Term Investments | 540k |
PP&E | 10.1m |
Intangibles | 85k |
Other Non-Current Assets | 1k |
Current Liabilities | 12.5m |
Accounts Payable | 5.4m |
Accrued Liabilities | 7.1m |
Other Current Liabilities | 11k |
Non-Current Liabilities | 64.2m |
Long-Term Debt | 58.5m |
Other Non-Current Liabilities | 5.7m |
Earnings Waterfall
Carmat SA
Revenue
|
5.5m
EUR
|
Cost of Revenue
|
-35.1m
EUR
|
Gross Profit
|
-29.6m
EUR
|
Operating Expenses
|
-22.4m
EUR
|
Operating Income
|
-52m
EUR
|
Other Expenses
|
-1.3m
EUR
|
Net Income
|
-53.4m
EUR
|
Free Cash Flow Analysis
Carmat SA
EUR | |
Free Cash Flow | EUR |
ALCAR Profitability Score
Profitability Due Diligence
Carmat SA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
Score
Carmat SA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
ALCAR Solvency Score
Solvency Due Diligence
Carmat SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Score
Carmat SA's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALCAR Price Targets Summary
Carmat SA
According to Wall Street analysts, the average 1-year price target for ALCAR is 7.723 EUR with a low forecast of 4.04 EUR and a high forecast of 18.9 EUR.
Dividends
Current shareholder yield for ALCAR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ALCAR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 160 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.
Contact
IPO
Employees
Officers
The intrinsic value of one ALCAR stock under the Base Case scenario is 4.995 EUR.
Compared to the current market price of 1.066 EUR, Carmat SA is Undervalued by 79%.